Results 26 - 30 of 147
Download (Excel compatible)
Thyroid method 2a: Thyroperoxidase (TPO) inhibition based on oxidation of Amplex UltraRed
TM Status: Closed
Test Method Number: TM2019-04 (EU)
Short Name of TM: AUR-TPO
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Thyroid method 1a: PATHHUNTER® BETA-ARRESTIN thyrotropin-releasing hormone (TRH) receptor activation (beta-galactosidase) measuring agonist and antagonist activities
TM Status: Closed
Test Method Number: TM2019-02 (EU)
Short Name of TM: TRH-CHOK1
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
GARDskin Dose-Response
TM Status: Open
Test Method Number: TM2025-01 (EU)
Short Name of TM: GARDSkin DR
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Skin sensitisation
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Blood-brain barrier-on-a-chip (BBB-oC) for drug testing of brain-targeting delivery
TM Status: Closed
Test Method Number: TM2024-01 (EU)
Short Name of TM: BBB-oC
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Human health
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Bioaccessibility testing (Bioelution) of metals, inorganic metals compounds and metals-containing materials: simulated gastric fluid
TM Status: Closed
Test Method Number: TM2016-02 (EU)
Short Name of TM: Bioelution
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Bioaccessibility
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards